Follow The Filings

DVA DaVita

Health Care, filed as DAVITA INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 2 Owners
  • Max 2.2%
  • $6.5B
  • 1 add 1 small

In 2026 Q2 Davidson Kempner Capital Management added to DaVita.

Who owns this now

Largest portfolio weights among holders, up to 2.2% (Warren Buffett, Berkshire Hathaway). Not free-float ownership.

  1. Warren Buffett Reduce 2.2%
  2. Davidson Kempner Capital Mana... Add 0.30%

Who owns DVA

Sorted by value, long equity only, as of 2026 Q2.

History
Warren Buffett, Berkshire Hathaway 2.2% Small trim −4.1% 28,880,209 $6.4B History
Davidson Kempner Capital Management 0.30%, was 0.07% Add +238.6% 113,098 $25M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DVA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DVA insider trades
  • None no insider bought on the open market
  • $520M sold by 5 insiders outside a trading plan
  • $3.6M sold by 2 insiders under 10b5-1 plans
  1. Berkshire Hathaway Inc. 10% owner, +1 joint filer
    Sale
    $69M 382,563 shares at $180.43 1.3% of stake
    Traded Oct 27 Filed Oct 29
    ↗
  2. Berkshire Hathaway Inc. 10% owner, +1 joint filer
    Sale
    $36.5M 182,980 shares at $199.55 0.6% of stake
    Traded Jul 31 Filed Aug 4
    ↗
  3. Kathleen Alyce Waters Chief Legal & Pub. Affairs Off
    Planned sale
    $3.2M 15,405 shares at $208.40 12% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  4. Javier Rodriguez CEO
    Sale
    $14.5M 69,407 shares at $209.38 7.6% of stake
    Traded Jun 15–16 Filed Jun 17
    ↗
  5. James O Hearty Chief Compliance Officer
    Sale
    $2.9M 15,000 shares at $193.98 40% of stake
    Traded May 15 Filed May 18
    ↗
  6. David Paul Maughan COO
    Sale
    $4.1M 20,529 shares at $199.22 18% of stake
    Traded May 11–12 Filed May 13
    ↗
  7. Joel Ackerman CFO
    Sale
    $9.9M 51,471 shares at $192.10 28% of stake
    Traded May 7 Filed May 11
    ↗
  8. James O Hearty Chief Compliance Officer
    Planned sale
    $382K 2,184 shares at $174.87 5.7% of stake
    Traded May 6 Filed May 8
    ↗
  9. Berkshire Hathaway Inc. 10% owner, +1 joint filer
    Sale
    $183M 1,220,376 shares at $149.84 4.1% of stake
    Traded May 1 Filed May 5
    ↗
  10. Berkshire Hathaway Inc. 10% owner, +1 joint filer
    Sale
    $200M 1,658,480 shares at $120.56 5.2% of stake
    Traded Jan 29 Filed Feb 2
    ↗
  11. Berkshire Hathaway Inc. 10% owner, +1 joint filer
    Sale
    $54.3M 401,514 shares at $135.36 1.2% of stake
    Traded Oct 27, 2025 Filed Oct 29, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 44 stock grants, 19 share withholdings for taxes, 4 sales back to the company, 4 option exercises, and 1 gift.

Congress

4 members of Congress traded DVA in the last three years: 2 buys and 5 sales. 3 members listed it in 2025 annual reports.

All Congress trades
  1. Julie Johnson D-TX-32Joint Sell $1K–$15K Sep 23, 2025 filed Aug 5
  2. Julie Johnson D-TX-32Joint Buy $1K–$15K Sep 23, 2025 filed Aug 5
  3. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  4. Julie Johnson D-TX-32Joint Sell $1K–$15K Sep 25, 2025 filed Oct 7, 2025
  5. Jerry Moran R-KS Sell $1K–$15K Dec 14, 2023 filed Jan 17, 2024
  6. Jerry Moran R-KSSpouse Sell $1K–$15K Dec 14, 2023 filed Jan 17, 2024

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A DEFINITIVE ADDITIONAL MATERIALS Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income $691.54M $936.34M $746.8M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.14B $3.75B $4.06B
Total non-current assets * $13.76B $13.54B $13.42B
Total assets $16.89B $17.29B $17.48B
Total current liabilities $2.64B $2.97B $3.14B
Total non-current liabilities * $11.51B $12.22B $13.18B
Total equity $1.06B $0.121B -$0.651B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $2.06B $2.02B $1.89B
Cash from investing -$771.8M -$771.43M -$654.95M
Cash from financing -$1.17B -$0.817B -$1.37B
Net change in cash $125.64M $415.19M -$122.08M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.